Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Sep;78(6):718–723. doi: 10.1038/bjc.1998.567

Enhanced expression of the urokinase-type plasminogen activator gene and reduced colony formation in soft agar by ectopic expression of PU.1 in HT1080 human fibrosarcoma cells.

N Kondoh 1, T Yamada 1, F Kihara-Negishi 1, M Yamamoto 1, T Oikawa 1
PMCID: PMC2062971  PMID: 9743289

Abstract

To investigate the cell biological function of PU.1, a member of the Ets family of transcription factors, a vector capable of expressing the protein was transfected into HT1080 human fibrosarcoma cells. Exogenous expression of PU.1 in HT1080 cells reduced colony-forming efficiency but stimulated cell migration in soft agar, although it did not affect cell growth in adherent culture. Expression of the urokinase-type plasminogen activator (uPA) mRNA, which is known to be correlated with cell migration and invasion, was enhanced in PU.1 transfectants compared with mock transfectants. Run-on analysis demonstrated that uPA transcription was unaffected by PU.1, suggesting that this enhancement mainly occurs at a post-transcriptional level. On the other hand, treatment of HT1080 cells with the synthetic glucocorticoid dexamethasone (DEX; 10(-7) M) significantly reduced uPA gene expression at a transcriptional level. Furthermore, DEX inhibited cell migration in soft agar without affecting cell growth. These negative effects of DEX on uPA expression and cell migration were alleviated by the expression of PU.1 in HT1080 cells, whereas expression of the N-ras oncogene, which is responsible for maintenance of the transformed phenotypes in HT1080 cells, was unaffected by PU.1 expression or DEX treatment in the cells. Our results suggest that expression of PU.1 can stimulate uPA gene expression at the post-transcriptional level, which may subsequently lead to activation of cell motility and/or reduced cell-cell adhesion, but reduces anchorage-independent growth of HT1080 cells.

Full text

PDF
718

Images in this article

719Figure 1
on p.719
719Figure 2
on p.719
720Figure 3
on p.720
721Figure 4
on p.721

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altus M. S., Nagamine Y. Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. Studies in vivo and in cell-free decay reactions. J Biol Chem. 1991 Nov 5;266(31):21190–21196. [PubMed] [Google Scholar]
  2. Altus M. S., Pearson D., Horiuchi A., Nagamine Y. Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability. Biochem J. 1987 Mar 1;242(2):387–392. doi: 10.1042/bj2420387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chambers S. K., Wang Y., Gertz R. E., Kacinski B. M. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res. 1995 Apr 1;55(7):1578–1585. [PubMed] [Google Scholar]
  4. Darby T. G., Meissner J. D., Rühlmann A., Mueller W. H., Scheibe R. J. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1. Oncogene. 1997 Dec 18;15(25):3067–3082. doi: 10.1038/sj.onc.1201503. [DOI] [PubMed] [Google Scholar]
  5. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  6. Galang C. K., Der C. J., Hauser C. A. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene. 1994 Oct;9(10):2913–2921. [PubMed] [Google Scholar]
  7. Gauthier J. M., Bourachot B., Doucas V., Yaniv M., Moreau-Gachelin F. Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J. 1993 Dec 15;12(13):5089–5096. doi: 10.1002/j.1460-2075.1993.tb06203.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gunning P., Ponte P., Kedes L., Hickey R. J., Skoultchi A. I. Expression of human cardiac actin in mouse L cells: a sarcomeric actin associates with a nonmuscle cytoskeleton. Cell. 1984 Mar;36(3):709–715. doi: 10.1016/0092-8674(84)90351-9. [DOI] [PubMed] [Google Scholar]
  9. Hall A., Marshall C. J., Spurr N. K., Weiss R. A. Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature. 1983 Jun 2;303(5916):396–400. doi: 10.1038/303396a0. [DOI] [PubMed] [Google Scholar]
  10. Henderson B. R., Kefford R. F. Conservation and potential role of RNA-instability motifs in urokinase gene 3'-untranslated sequences. J Natl Cancer Inst. 1991 Aug 7;83(15):1103–1104. doi: 10.1093/jnci/83.15.1103. [DOI] [PubMed] [Google Scholar]
  11. Henderson B. R., Tansey W. P., Phillips S. M., Ramshaw I. A., Kefford R. F. Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res. 1992 May 1;52(9):2489–2496. [PubMed] [Google Scholar]
  12. Huang H. J., Yee J. K., Shew J. Y., Chen P. L., Bookstein R., Friedmann T., Lee E. Y., Lee W. H. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science. 1988 Dec 16;242(4885):1563–1566. doi: 10.1126/science.3201247. [DOI] [PubMed] [Google Scholar]
  13. Kondoh N., Oikawa T., Satoh C., Kuzumaki N. Effects of sodium butyrate on the rearranged c-myc expression in mouse plasmacytoma cells. Exp Cell Res. 1991 Sep;196(1):146–149. doi: 10.1016/0014-4827(91)90469-b. [DOI] [PubMed] [Google Scholar]
  14. Kondoh N., Schweinfest C. W., Henderson K. W., Papas T. S. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res. 1992 Feb 15;52(4):791–796. [PubMed] [Google Scholar]
  15. Langer S. J., Bortner D. M., Roussel M. F., Sherr C. J., Ostrowski M. C. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol Cell Biol. 1992 Dec;12(12):5355–5362. doi: 10.1128/mcb.12.12.5355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Littlefield B. A., Johnston L. J., Manzer D. S., Roche P. C. Glucocorticoid inhibition of urokinase-like plasminogen activators in cultured human lymphoblasts. Endocrinology. 1985 Sep;117(3):1100–1109. doi: 10.1210/endo-117-3-1100. [DOI] [PubMed] [Google Scholar]
  17. Medcalf R. L., Richards R. I., Crawford R. J., Hamilton J. A. Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. EMBO J. 1986 Sep;5(9):2217–2222. doi: 10.1002/j.1460-2075.1986.tb04487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moreau-Gachelin F. Spi-1/PU.1: an oncogene of the Ets family. Biochim Biophys Acta. 1994 Dec 30;1198(2-3):149–163. doi: 10.1016/0304-419x(94)90011-6. [DOI] [PubMed] [Google Scholar]
  19. Moreau-Gachelin F., Tavitian A., Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature. 1988 Jan 21;331(6153):277–280. doi: 10.1038/331277a0. [DOI] [PubMed] [Google Scholar]
  20. Moreau-Gachelin F., Wendling F., Molina T., Denis N., Titeux M., Grimber G., Briand P., Vainchenker W., Tavitian A. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol. 1996 May;16(5):2453–2463. doi: 10.1128/mcb.16.5.2453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nerlov C., Rørth P., Blasi F., Johnsen M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene. 1991 Sep;6(9):1583–1592. [PubMed] [Google Scholar]
  22. Paterson H., Reeves B., Brown R., Hall A., Furth M., Bos J., Jones P., Marshall C. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell. 1987 Dec 4;51(5):803–812. doi: 10.1016/0092-8674(87)90103-6. [DOI] [PubMed] [Google Scholar]
  23. Paul R., Schuetze S., Kozak S. L., Kozak C. A., Kabat D. The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J Virol. 1991 Jan;65(1):464–467. doi: 10.1128/jvi.65.1.464-467.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schuetze S., Stenberg P. E., Kabat D. The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol Cell Biol. 1993 Sep;13(9):5670–5678. doi: 10.1128/mcb.13.9.5670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Simon M. C., Olson M., Scott E., Hack A., Su G., Singh H. Terminal myeloid gene expression and differentiation requires the transcription factor PU.1. Curr Top Microbiol Immunol. 1996;211:113–119. doi: 10.1007/978-3-642-85232-9_11. [DOI] [PubMed] [Google Scholar]
  26. Stacey K. J., Fowles L. F., Colman M. S., Ostrowski M. C., Hume D. A. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol Cell Biol. 1995 Jun;15(6):3430–3441. doi: 10.1128/mcb.15.6.3430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Suzuki H., Romano-Spica V., Papas T. S., Bhat N. K. ETS1 suppresses tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4442–4446. doi: 10.1073/pnas.92.10.4442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Taparowsky E., Shimizu K., Goldfarb M., Wigler M. Structure and activation of the human N-ras gene. Cell. 1983 Sep;34(2):581–586. doi: 10.1016/0092-8674(83)90390-2. [DOI] [PubMed] [Google Scholar]
  29. Verde P., Stoppelli M. P., Galeffi P., Di Nocera P., Blasi F. Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4727–4731. doi: 10.1073/pnas.81.15.4727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wasylyk B., Wasylyk C., Flores P., Begue A., Leprince D., Stehelin D. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature. 1990 Jul 12;346(6280):191–193. doi: 10.1038/346191a0. [DOI] [PubMed] [Google Scholar]
  31. Wasylyk C., Maira S. M., Sobieszczuk P., Wasylyk B. Reversion of Ras transformed cells by Ets transdominant mutants. Oncogene. 1994 Dec;9(12):3665–3673. [PubMed] [Google Scholar]
  32. Yamada T., Kondoh N., Matsumoto M., Yoshida M., Maekawa A., Oikawa T. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood. 1997 Feb 15;89(4):1383–1393. [PubMed] [Google Scholar]
  33. Ziegler A., Hagmann J., Kiefer B., Nagamine Y. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism. J Biol Chem. 1990 Dec 5;265(34):21194–21201. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES